Q1 2023 Holdings
Filed 2023-05-15 | 72 holdings | $252.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $110.7M | 3,570,872 | 43.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $75.6M | 4,557,414 | 29.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $18.5M | 300,000 | 7.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $15.1M | 1,821,739 | 6.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $10.4M | 296,000 | 4.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.6M | 700,000 | 3.0% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $5.2M | 1,547,181 | 2.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $4.8M | 1,250,000 | 1.9% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $2.8M | 612,079 | 1.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $722.0K | 392,167 | 0.3% |
| Prometheus Biosciences Inc | COM | 74349U108 | $177.6K | 1,655,000 | 0.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $147.4K | 6,892,101 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $89.7K | 1,360,000 | 0.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $75.8K | 8,500,000 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $49.3K | 1,600,000 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $42.6K | 2,800,000 | 0.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $42.4K | 1,936,133 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $40.1K | 2,612,115 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $39.1K | 1,700,000 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $38.4K | 1,444,000 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $32.5K | 10,813,246 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $31.5K | 1,561,696 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $29.7K | 5,150,000 | 0.0% |
| Rain Oncology Inc | COM | 75082Q105 | $26.0K | 2,978,660 | 0.0% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $23.2K | 2,386,181 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $22.5K | 2,893,717 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $21.6K | 850,000 | 0.0% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $21.6K | 2,536,617 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $19.7K | 2,946,887 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $17.9K | 1,421,422 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $17.6K | 322,240 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $17.5K | 1,050,000 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $16.3K | 4,116,949 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $15.2K | 110,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $14.9K | 868,550 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $14.5K | 80,000 | 0.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $13.7K | 576,373 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $13.3K | 1,000,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $12.2K | 325,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $11.9K | 650,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $11.1K | 1,271,429 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $10.7K | 3,082,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $10.3K | 275,000 | 0.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $9.4K | 2,353,141 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $9.1K | 1,087,807 | 0.0% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $9.0K | 734,350 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $8.3K | 4,250,000 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $6.6K | 816,460 | 0.0% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $6.0K | 616,786 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $5.0K | 350,000 | 0.0% |